02.02.2016 - Forecasts on revenue of Pfizer have led to a deterioration in investor expectations
Pharmaceutical giant Pfizer has reported on the results in the 4th quarter of last year. Thus, profit fell to 613 million dollars against 1.228 billion dollars in the same period in 2014. At the same time, revenue rose to 14.05 billion against the forecast of 13.58 billion. Negative factor was the reduction in forecast of revenue for 2016 year to 49-51 billion dollars against the previous estimates at 53 billion. We expect a decrease in quotations in the near future.